Pipeline forecasting can provide payers better insight into which expensive specialty drugs coming down the pipeline they should be keeping their eyes on, according to Katie Lockhart, MA, manager at Magellan Health.
Pipeline forecasting can provide payers better insight into which expensive specialty drugs coming down the pipeline they should be keeping their eyes on, according to Katie Lockhart, MA, manager at Magellan Health.
Transcript:
How is the growing specialty pipeline expected to impact payers financially?
Specialty is definitely the big topic in pharma right now within payers and everything, just simply because it's really cool on the one hand being able to treat diseases that we've never been able to treat before that had very limited treatment options, which is really great. Unfortunately, though, those things also come with a high cost due to the fact that there's a high cost in manufacturing and developing some of these things like the gene therapy drugs and CAR T [chimeric antigen receptor T-cell] therapies. So, because that has a high impact on payers, payers right now are especially interested in this. Because 1 drug that could release could have a significant impact on their budget and so they need to be prepared for that.
So, that's where forecasting has come in, and has been a big part and where we've seen a lot more questions around asking about what is the potential impact of this drug. Is this a blockbuster drug? Is this something that potentially I need to be prepared for? Because it could increase my spend significantly, whereas maybe in the past, that hasn't been as true. Now, with these newer treatment options and their high cost, that is becoming a higher concern.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More